Furthermore, based on the result shown in Fig. 4, serial longitudinal measurement of serum SP-D might address the crucial unmet need in the field of IPF research regarding the identification of specific molecular pathways for treatment (pharmacodynamic biomarker). The gene discussed is SFTPD; the disease is idiopathic pulmonary fibrosis.